CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 497 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00001619
NCT00001619N/ACompleted

Magnetic Resonance at 1.5 and 3 Tesla

National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted Nov 4, 1999·Updated Jul 2, 2017

In Brief

An observational study for Cardiovascular Disease and Healthy. Completed, enrolled 497 participants across 1 site.

Detailed Summary

Magnetic resonance imaging (MRI) is a diagnostic tool that creates high quality images of the human body without the use of X-ray (radiation). MRI uses different levels of magnetic fields to create images of the body and organs. Occasionally, researchers will give patients undergoing a MRI an injection of a substance called gadolinium. Gadolinium works by brightening areas of the magnetic resonance image, thereby improving the contrast. In this study researchers will use magnetic resonance imaging and contrast substances, like gadolinium, on normal volunteers in order to evaluate different aspects of its performance. Information gathered from this study may be used to develop more specific research studies involving MRI.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 4, 1999
Enrollment StartNov 5, 1996
Study CompletionJul 20, 2011
TodayJul 2, 2026
Posted 26.7 years ago